Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
    Journal Article

    Kudo, R.; Safonov, A.; Jones, C.; Moiso, E.; Dry, J. R.; Shao, H.; Nag, S.; da Silva, E. M.; Yildirim, S. Y.; Li, Q.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab
    Review

    Jabbour, E. J.; Kantarjian, H. M.; Goekbuget, N.; Shah, B. D.; Chiaretti, S.; Park, J. H.; Rijneveld, A. W.; Gore, L.; Fleming, S.; Logan, A. C.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • A view of myeloid transformation through the hallmarks of cancer
    Review

    Fernández-Maestre, I.; Cai, S. F.; Levine, R. L.
    Blood Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy
    Journal Article

    Hoff, F. W.; Blum, W. G.; Huang, Y.; Welkie, R. L.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Archer, K. J.; Patel, P. A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Lung neuroendocrine neoplasms harboring ALK, RET and other receptor tyrosine kinase fusions: Spectrum of pathologic features from conventional neuroendocrine carcinomas to unusual carcinoid-type tumors with focal mucin or adenocarcinoma components
    Meeting Abstract

    Armstrong, S.; Chang, J.; Yang, S. R.; Samuel, T.; Hussain, S.; Velez, M.; Baine, M.; Travis, W.; Drilon, A.; Quintanal-Villalonga, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Oncocytic variant of pancreatic neuroendocrine tumors are associated with aggressive characteristics
    Meeting Abstract

    Tarcan, Z.; Ozcan, K.; Xue, Y.; Raj, N.; Urganci, N.; Klimstra, D.; Volkan Adsay, N.; Basturk, O.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A model for approaching pathologic assessment of treatment response to neoadjuvant chemotherapy in resected pleural mesothelioma
    Meeting Abstract

    Aly, R. G.; Offin, M.; Tan, K. S.; Bodd, F.; Adusumilli, P.; Travis, W.; Zauderer, M.; Sauter, J.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Validation of the recently proposed sub-grading of G2 pancreatic neuroendocrine tumors as G2a (Ki67 index 3% - <10%) versus G2b (10% - 20%)
    Meeting Abstract

    Eren, O. C.; Tarcan, Z.; Esmer, R.; Luchini, C.; Raj, N.; Scarpa, A.; Basturk, O.; Volkan Adsay, N.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma histologic subtypes correlate with hidden-genome classification
    Meeting Abstract

    Kumar, S.; Raquele, L.; Song, Y.; Drill, E.; Vakiani, E.; Chandwani, R.; Harding, J.; Jarnagin, W.; Sigel, C.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save